1,425 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Medline Industries recalled 16 units of IV Administration Sets on November 26, 2025. Customers reported check valve components may become stuck, posing a risk during use. Healthcare providers should stop using these devices immediately and follow recall instructions.
Medline Industries recalled 5,314 IV Administration Sets on November 26, 2025. The recall affects several product SKUs due to potential failure of check valve components. Patients and healthcare providers should stop using these devices immediately.
Taro Pharmaceuticals recalled Clindamycin Phosphate USP, 1% topical solution on November 26, 2025. The recall affects specific lots due to failed impurity testing. Consumers should stop using the product immediately and consult healthcare providers.
Medline Industries recalled 33 units of IV Administration Sets on November 26, 2025. The recall follows customer complaints about check valve components potentially becoming stuck. This defect poses a high risk to patient safety and requires immediate action from healthcare providers.
Medline Industries recalled 633 units of IV administration sets on November 26, 2025. The recall follows complaints that check valve components may become stuck, posing a high risk to patient safety. Healthcare providers and patients must stop using affected products immediately.
Medline Industries recalled 338 IV Administration Sets on November 26, 2025. The recall stems from complaints about malfunctioning check valve components. Patients and healthcare providers must stop using these devices immediately.
Medline Industries recalled 35,694 Full Electric Lightweight Homecare Beds on November 26, 2025, due to a fire hazard. The hand control pendant may overheat under certain conditions, leading to potential fire risks. The company received 58 complaints related to sparking and burning incidents.
Medline Industries recalled 138,412 electric homecare beds on November 26, 2025. Hazardous hand control pendants may overheat and pose a fire risk. The recall follows 58 reports of sparking, burning, and smoking incidents.
Medline Industries recalled 15,581 electric homecare beds on November 26, 2025, due to a fire hazard. The hand control pendant may overheat, posing a risk of fire in rare cases. The recall follows 58 complaints of sparking or burning from the pendant.
Medline Industries recalled 13,245 homecare beds on November 26, 2025, due to a fire risk from the hand control pendant. The company received 58 reports of sparking, burning, and smoke. Patients and healthcare providers must stop using the beds immediately and follow recall instructions.
Ferndale Laboratories recalled 24,589 vials of Mastisol Liquid Adhesive due to a defect. The butyrate tube may crack during use, making the product unusable. The recall affects products distributed in the U.S. and the U.K., announced on November 25, 2025.
Abbott Diabetes Care recalled over 1 million FreeStyle Libre 3 sensors on November 24, 2025, due to a manufacturing issue. The defect may lead to incorrect low glucose readings, posing a serious health risk. Affected sensors were distributed across the U.S. and several international markets.
Alcon Laboratories, Inc. recalled 151 units of Custom Pak surgical procedure packs on November 24, 2025. The recall stems from incomplete seals that may affect sterility. Healthcare providers and patients should stop using the products immediately.
Breckenridge Pharmaceutical, Inc. recalled 7,389 bottles of Duloxetine Delayed-Release Capsules on November 24, 2025. The recall stems from CGMP deviations and the presence of N-nitroso-duloxetine impurity above FDA limits. Consumers should stop using the product immediately and contact healthcare providers for guidance.
Towa Pharmaceuticals recalled 3,397 bottles of Duloxetine Delayed-Release Capsules on November 24, 2025. The recall stems from CGMP deviations resulting in N-nitroso-duloxetine levels exceeding FDA limits. Consumers must stop using the product immediately.
Draeger, Inc. recalled 188 units of the Vapor 3000 anesthetic vaporizer on November 24, 2025. The devices contained impurities in a component not delivered within specification. Healthcare providers and patients must stop using the devices immediately.
Draeger, Inc. recalled 431 units of the Vapor 2000 anesthetic vaporizer on November 24, 2025. A component of the devices contained impurities and did not meet specifications, posing a high hazard risk. Healthcare providers and patients should cease use immediately and follow recall instructions.
ICU Medical recalled the LifeShield Infusion Safety Software Suite v2.2 on November 24, 2025. The software fails to operate as expected for migrated libraries, risking medication delivery errors. The recall affects seven customers across several states, including California and New York.
ICU Medical recalled LifeShield Drug Library Management software on November 24, 2025. A software issue limits concentration precision to one decimal place, risking incorrect drug dosages. Users should stop using the product immediately and follow recall instructions.
Abbott Diabetes Care recalled 258,913 FreeStyle Libre 3 Plus sensors on November 24, 2025. Manufacturing issues may lead to incorrect low glucose results, posing a high risk to users. Consumers should stop using the device immediately and follow the recall instructions.
Abbott Diabetes Care recalled 1,663,241 FreeStyle Libre 3 Plus sensors on November 24, 2025. A manufacturing issue may lead to incorrect low glucose results, creating serious health risks for users. Patients should stop using the sensors immediately and follow recall instructions.
Abbott Diabetes Care recalled 8,062 FreeStyle Libre 3 Plus sensors on November 24, 2025. A manufacturing issue may cause inaccurate low glucose readings, posing serious health risks. Consumers should stop using the device immediately and follow recall instructions.
LotFancy recalled 91,366 urinary tract infection test strips on November 22, 2025. The strips may produce false results, risking inappropriate medical intervention. Affected products include various models sold nationwide in states like Texas, Georgia, and California.
Changchun Wancheng Bio-Electron Co. recalled 1,000 units of S. Typhi/Para Typhi A Antigen test strips on November 22, 2025. The recall affects tests distributed nationwide, which may produce false results and lead to inappropriate medical intervention.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.